Literature DB >> 21137607

Sporotrichosis: Part I.

Regina Casz Schechtman1.   

Abstract

Sporotrichosis is the most common subcutaneous mycosis in South America. Classic infection is associated with traumatic inoculation of soil, vegetables, and organic material contaminated with Sporothix schenckii. Animals of various species, including humans, are affected by this disease. This subcutaneous mycosis is an infection of implantation. The most frequent clinical form is the lymphocutaneous form. The fixed cutaneous form is characterized by infiltrated nodular, ulcerated, or erythematosquamous lesions located on exposed areas where fungal inoculation occurred. The disseminated cutaneous forms have mainly been observed among immunosuppressed patients, especially human immunodeficiency virus-positive individuals. Sporotrichosis is the only subcutaneous mycosis for which direct examination or histology is of little or no value for diagnosis. The diagnosis rests solely on the isolation of S schenckii in culture. Since 1998, researchers from Brazil suggested that feline transmission of sporotrichosis was associated with a large and long-lasting outbreak of the disease in the city of Rio de Janeiro.

Entities:  

Mesh:

Year:  2010        PMID: 21137607

Source DB:  PubMed          Journal:  Skinmed        ISSN: 1540-9740


  8 in total

1.  Seroepidemiological survey on sporotrichosis-infection in rural areas of the south of Minas Gerais State, Brazil.

Authors:  Julianne Caravita Grisolia; Lauana Aparecida Santos; Letícia Maria Leomil Coelho; Roberta Ribeiro Silva; Zoilo Pires de Camargo; Tania Regina Grão Velloso; Luiz Felipe Leomil Coelho; Jorge Kleber Chavasco; Luiz Cosme Cotta Malaquias
Journal:  Braz J Microbiol       Date:  2020-05-13       Impact factor: 2.476

2.  Effects of metaperiodate and urea solutions on the serological diagnosis of human sporotrichosis using an indirect ELISA test.

Authors:  Leila Maria Lopes Bezerra; Letícia Maria Leomil Coelho; Julianne Caravita Grisolia; Maria Lúcia; Míriam Boczar; Eric Batista Ferreira; Denismar Alves Nogueira; Jorge Kleber Chavasco; Zoilo Pires de Camargo; Luiz Felipe Leomil Coelho; Luiz Cosme Cotta Malaquias
Journal:  Braz J Microbiol       Date:  2018-12-13       Impact factor: 2.476

3.  The Efficacy of Humanized Antibody against the Sporothrix Antigen, gp70, in Promoting Phagocytosis and Reducing Disease Burden.

Authors:  José R F de Almeida; Karla L Santiago; Gilberto H Kaihami; Andrea Q Maranhão; Marcelo de Macedo Brígido; Sandro R de Almeida
Journal:  Front Microbiol       Date:  2017-03-03       Impact factor: 5.640

4.  An immunoproteomic approach revealing peptides from Sporothrix brasiliensis that induce a cellular immune response in subcutaneous sporotrichosis.

Authors:  José Roberto Fogaça de Almeida; Grasielle Pereira Jannuzzi; Gilberto Hideo Kaihami; Leandro Carvalho Dantas Breda; Karen Spadari Ferreira; Sandro Rogério de Almeida
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

5.  Sporotrichosis: hyperendemic by zoonotic transmission, with atypical presentations, hypersensitivity reactions and greater severity.

Authors:  Regina Casz Schechtman; Eduardo Mastrangelo Marinho Falcão; Marciela Carard; Maria Salomé Cajas García; Diana Stohmann Mercado; Roderick James Hay
Journal:  An Bras Dermatol       Date:  2021-12-08       Impact factor: 1.896

Review 6.  Sporotrichosis: a Comprehensive Review on Recent Drug-Based Therapeutics and Management.

Authors:  Bunty Sharma; Anil Kumar Sharma; Ujjawal Sharma
Journal:  Curr Dermatol Rep       Date:  2022-03-17

Review 7.  Cutaneous Disseminated and Extracutaneous Sporotrichosis: Current Status of a Complex Disease.

Authors:  Alexandro Bonifaz; Andrés Tirado-Sánchez
Journal:  J Fungi (Basel)       Date:  2017-02-10

8.  Skin Mast Cells Contribute to Sporothrix schenckii Infection.

Authors:  Qingqing Jiao; Ying Luo; Jörg Scheffel; Peng Geng; Yuhan Wang; Stefan Frischbutter; Ruoyu Li; Marcus Maurer; Zuotao Zhao
Journal:  Front Immunol       Date:  2020-03-19       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.